AYTU BIOPHARMA, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of _______, 20__ Debt SecuritiesIndenture • September 28th, 2021 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 28th, 2021 Company Industry JurisdictionWHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;